You are here

Article info

Article menu
Download PDFPDF
New disease loci
Short report
VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2)

Authors

  • Miora Feinstein Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Hagit Flusser Zussman Child Development Center, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Tally Lerman-Sagie Pediatric Neurology Unit, Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel PubMed articlesGoogle scholar articles
  • Bruria Ben-Zeev Pediatric Neurology Unit, Sheba Medical Center, Ramat-Gan, Israel PubMed articlesGoogle scholar articles
  • Dorit Lev Pediatric Neurology Unit, Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel PubMed articlesGoogle scholar articles
  • Orly Agamy Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Idan Cohen Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Rotem Kadir Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Sara Sivan Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Esther Leshinsky-Silver Pediatric Neurology Unit, Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel PubMed articlesGoogle scholar articles
  • Barak Markus Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  • Ohad S Birk Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev and Faculty of Health Sciences, Ben Gurion University, Beer Sheva, IsraelGenetics Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ohad S Birk, Genetics Institute, Soroka Medical Center, Beer-Sheva 84101, Israel; obirk{at}bgu.ac.il
View Full Text

Citation

Feinstein M, Flusser H, Lerman-Sagie T, et al
VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2)
Journal of Medical Genetics 2014;51:303-308.

Publication history

  • Received May 23, 2013
  • Revised January 6, 2014
  • Accepted February 3, 2014
  • First published February 27, 2014.
Online issue publication 
April 27, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions